These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 35986318)

  • 1. Apoptosis and autophagy markers predict survival in neoadjuvant treated oesophageal adenocarcinoma patients.
    El Mashed S; O'Donovan TR; Kay E; O'Grady A; McManus D; Turkington RC; McKenna SL
    BMC Cancer; 2022 Aug; 22(1):908. PubMed ID: 35986318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC3B globular structures correlate with survival in esophageal adenocarcinoma.
    El-Mashed S; O'Donovan TR; Kay EW; Abdallah AR; Cathcart MC; O'Sullivan J; O'Grady A; Reynolds J; O'Reilly S; O'Sullivan GC; McKenna SL
    BMC Cancer; 2015 Aug; 15():582. PubMed ID: 26265176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High PTGS2 expression in post-neoadjuvant chemotherapy-treated oesophageal adenocarcinoma is associated with improved survival: a population-based cohort study.
    Spence AD; Trainor J; McMenamin Ú; Turkington RC; McQuaid S; Bingham V; James J; Salto-Tellez M; McManus DT; Johnston BT; Cardwell CR; Coleman HG
    Histopathology; 2019 Mar; 74(4):587-596. PubMed ID: 30408225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspase-cleaved cytokeratin-18 and tumour regression in gastro-oesophageal adenocarcinomas treated with neoadjuvant chemotherapy.
    Fareed KR; Soomro IN; Hameed K; Arora A; Lobo DN; Parsons SL; Madhusudan S
    World J Gastroenterol; 2012 Apr; 18(16):1915-20. PubMed ID: 22563171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy.
    Fareed KR; Al-Attar A; Soomro IN; Kaye PV; Patel J; Lobo DN; Parsons SL; Madhusudan S
    Br J Cancer; 2010 May; 102(11):1600-7. PubMed ID: 20461087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas.
    Bain GH; Collie-Duguid E; Murray GI; Gilbert FJ; Denison A; McKiddie F; Ahearn T; Fleming I; Leeds J; Phull P; Park K; Nanthakumaran S; Matula KM; Grabsch HI; Tan P; Welch A; Schweiger L; Dahle-Smith A; Urquhart G; Finegan M; Petty RD
    Br J Cancer; 2014 Mar; 110(6):1525-34. PubMed ID: 24569475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A specific expression profile of LC3B and p62 is associated with nonresponse to neoadjuvant chemotherapy in esophageal adenocarcinomas.
    Adams O; Janser FA; Dislich B; Berezowska S; Humbert M; Seiler CA; Kroell D; Slotta-Huspenina J; Feith M; Ott K; Tschan MP; Langer R
    PLoS One; 2018; 13(6):e0197610. PubMed ID: 29897944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The residual tumor autophagy marker LC3B serves as a prognostic marker in local advanced breast cancer after neoadjuvant chemotherapy.
    Chen S; Jiang YZ; Huang L; Zhou RJ; Yu KD; Liu Y; Shao ZM
    Clin Cancer Res; 2013 Dec; 19(24):6853-62. PubMed ID: 24141623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial imaging using [18F]Fluorodeoxyglucose positron emission tomography and histopathologic assessment in predicting survival in a population of surgically resectable distal oesophageal and gastric adenocarcinoma following neoadjuvant therapy.
    Manoharan V; Lee S; Chong S; Yap J; Coupe N; Wilson R; Merrett N; Ng W; Lin M
    Ann Nucl Med; 2017 May; 31(4):315-323. PubMed ID: 28299585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of autophagy markers LC3B and p62 in esophageal adenocarcinomas.
    Adams O; Dislich B; Berezowska S; Schläfli AM; Seiler CA; Kröll D; Tschan MP; Langer R
    Oncotarget; 2016 Jun; 7(26):39241-39255. PubMed ID: 27250034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autophagy and Apoptosis Play Opposing Roles in Overall Survival of Esophageal Squamous Cell Carcinoma.
    Chen HI; Tsai HP; Chen YT; Tsao SC; Chai CY
    Pathol Oncol Res; 2016 Oct; 22(4):699-705. PubMed ID: 26980476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinoma.
    van der Kaaij RT; Snaebjornsson P; Voncken FE; van Dieren JM; Jansen EP; Sikorska K; Cats A; van Sandick JW
    Eur J Cancer; 2017 May; 76():27-35. PubMed ID: 28262585
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer.
    Lim SH; Hong M; Ahn S; Choi YL; Kim KM; Oh D; Ahn YC; Jung SH; Ahn MJ; Park K; Zo JI; Shim YM; Sun JM
    Eur J Cancer; 2016 Jan; 52():1-9. PubMed ID: 26623522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of HSP27 and the Autophagy Marker LC3B
    Livingston JA; Wang WL; Tsai JW; Lazar AJ; Leung CH; Lin H; Advani S; Daw N; Santiago-O'Farrill J; Hollomon M; Gordon NB; Kleinerman ES
    Mol Cancer Ther; 2018 Jun; 17(6):1315-1323. PubMed ID: 29592877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CD8
    Koemans WJ; van Dieren JM; van den Berg JG; Meijer GA; Snaebjornsson P; Chalabi M; Lecot F; Riedl R; Krijgsman O; Hofland I; Broeks A; Voncken FEM; Peppelenbosch MP; Sosef MN; van Sandick JW; Kodach LL
    Histopathology; 2021 Aug; 79(2):238-251. PubMed ID: 33660299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
    Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
    J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International Tumor Budding Consensus Conference criteria determine the prognosis of oesophageal adenocarcinoma with poor response to neoadjuvant treatment.
    Lohneis P; Rohmann J; Gebauer F; Hieggelke L; Bruns C; Schröder W; Büttner R; Löser H; Quaas A
    Pathol Res Pract; 2022 Apr; 232():153844. PubMed ID: 35316631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer.
    Bortnik S; Tessier-Cloutier B; Leung S; Xu J; Asleh K; Burugu S; Magrill J; Greening K; Derakhshan F; Yip S; Ng T; Gelmon KA; Nielsen TO; Gorski SM
    Breast Cancer Res Treat; 2020 Oct; 183(3):525-547. PubMed ID: 32685993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
    World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.